The Axin-like protein PRY-1 is a negative regulator of a canonical Wnt pathway in C. elegans

  1. Hendrik C. Korswagen1,3,4,
  2. Damien Y.M. Coudreuse1,3,
  3. Marco C. Betist1,
  4. Sandra van de Water1,
  5. Danica Zivkovic1, and
  6. Hans C. Clevers2
  1. 1Hubrecht Laboratory, Netherlands Institute for Developmental Biology, 3584 CT Utrecht, The Netherlands; 2Department of Immunology and Center for Biomedical Genetics, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands

Abstract

Axin, APC, and the kinase GSK3β are part of a destruction complex that regulates the stability of the Wnt pathway effector β-catenin. In C. elegans, several Wnt-controlled developmental processes have been described, but an Axin ortholog has not been found in the genome sequence and SGG-1/GSK3β, and the APC-related protein APR-1 have been shown to act in a positive, rather than negative fashion in Wnt signaling. We have shown previously that the EGL-20/Wnt-dependent expression of the homeobox gene mab-5 in the Q neuroblast lineage requires BAR-1/β-catenin and POP-1/Tcf. Here, we have investigated how BAR-1 is regulated by the EGL-20 pathway. First, we have characterized a negative regulator of the EGL-20 pathway,pry-1. We show that pry-1 encodes an RGS and DIX domain-containing protein that is distantly related to Axin/Conductin. Our results demonstrate that despite its sequence divergence, PRY-1 is a functional Axin homolog. We show that PRY-1 interacts with BAR-1, SGG-1, and APR-1 and that overexpression of PRY-1 inhibitsmab-5 expression. Furthermore, pry-1 rescues the zebrafish axin1 mutation masterblind, showing that it can functionally interact with vertebrate destruction complex components. Finally, we show that SGG-1, in addition to its positive regulatory role in early embryonic Wnt signaling, may function as a negative regulator of the EGL-20 pathway. We conclude that a highly divergent destruction complex consisting of PRY-1, SGG-1, and APR-1 regulates BAR-1/β-catenin signaling in C. elegans.

Keywords

Footnotes

  • 3 These authors contributed equally to this work.

  • 4 Corresponding author.

  • E-MAIL rkors{at}niob.knaw.nl; FAX 31-30-251-6464.

  • Article and publication are at http://www.genesdev.org/cgi/doi/10.1101/gad.981802.

    • Received February 4, 2002.
    • Accepted April 8, 2002.
| Table of Contents

Life Science Alliance